Nymox Pharmaceutical Corporation (NYMX)
Create an Alert
5.31
+0.10 +1.92%
NASDAQ
Jun 18, 5:00PM
BATS Real time
Currency in USD
Nymox Pharmaceutical Corporation Net Interest Income Quarterly:
-0.0069M for Dec. 31, 2012Nymox Pharmaceutical Corporation Historical Net Interest Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -0.0069M |
| Sept. 30, 2012 | -0.013M |
| June 30, 2012 | -0.0059M |
| March 31, 2012 | -0.0071M |
| Dec. 31, 2011 | -0.027M |
| Sept. 30, 2011 | 0.0019M |
| June 30, 2011 | -0.0121M |
| March 31, 2011 | -0.0218M |
| Dec. 31, 2010 | -0.0283M |
| Sept. 30, 2010 | -0.0011M |
| June 30, 2010 | -0.0012M |
| March 31, 2010 | -0.0006M |
| Dec. 31, 2009 | -0.0015M |
| Sept. 30, 2009 | -0.001M |
| June 30, 2009 | -0.0011M |
| March 31, 2009 | -0.0013M |
| Dec. 31, 2008 | -0.0016M |
| Sept. 30, 2008 | -0.0012M |
| June 30, 2008 | -0.0006M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Interest Income
Revenues from interest-bearing assets. A typical example would be interest earned by a bank on personal or commercial loans.
Learn More
NYMX Net Interest Income Quarterly Benchmarks
| Companies | |
|---|---|
| Anika Therapeutics | -0.0396M |
| Anacor Pharmaceuticals | -0.987M |
| Repligen Corporation | 0.048M |
NYMX Net Interest Income Quarterly Rankings
| Overall |
80th percentile 3296 of 16773 |
| Sector |
77th percentile 323 of 1408 in Healthcare |
| Industry |
67th percentile 149 of 453 in Biotechnology |
NYMX Net Interest Income Quarterly Range, Past 5 Years
| Minimum | -0.0283M | Dec 2010 |
| Maximum | 0.0019M | Sep 2011 |
| Average | -0.0069M |
